fosamprenavir has been researched along with phentolamine in 1 studies
Studies (fosamprenavir) | Trials (fosamprenavir) | Recent Studies (post-2010) (fosamprenavir) | Studies (phentolamine) | Trials (phentolamine) | Recent Studies (post-2010) (phentolamine) |
---|---|---|---|---|---|
174 | 55 | 37 | 9,141 | 270 | 265 |
Protein | Taxonomy | fosamprenavir (IC50) | phentolamine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.396 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.006 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 10 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.018 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.11 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0492 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0173 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.359 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.396 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0011 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0108 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.807 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0316 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.5495 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for fosamprenavir and phentolamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |